Mahoney Stephen F.'s Form 4 filing
Viridian Therapeutics, Inc. (VRDN) · filed Sep 30, 2024
- Accession no.
- 0000950170-24-110484
- Filed
- Sep 30, 2024
- Trade date
- Sep 27, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $499.3K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahoney Stephen F.CIK 0001741389 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Common Stock | PPurchaseAcquired | +21,400 | $23.33 | +$499,262 | 21,400 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.